Although acetylcholine esterase (AchE) inhibitors such as donepezil and galantamine and N-methyl-D-aspartate receptor blockers such as memantine have been established to be effective in improving the symptoms of dementia, they have not been shown to change the long-term outcome of the disease3–6. The gene discussed is ACHE; the disease is dementia.